Investigating Abnormal Lipid Layer Thickness in Blepharoplasty Patients
NCT01787942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2014-08-19
Summary
Deficiency in tear film lipid layer thickness (LLT) has been implicated in the development of dry eye symptoms, and is influenced to a significant degree by the anatomy and function of the eyelids. Patients who are considering blepharoplasty, even if it is for cosmetic reasons, may subtle differences in eyelid anatomy that pre-dispose them to having an abnormal tear lipid layer. Moreover, the changes in anatomy and contour of the eyelids following blepharoplasty introduce a whole new group of factors, such as an altered palpebral aperture and altered canthal fixation that can further change the eyelid's ability to maintain a healthy tear lipid layer, for better or for worse. Such changes in tear lipid layer can be detected with the aid of a newly acquired tear interferometer (LipiView, Tearscience Inc.), but has never been done in the context of blepharoplasty management. Due to the strong association between LLT and risk of dry eyes, we hope to investigate if there are significant differences in LLT and other objective dry eye parameters in two situations: 1) patients considering blepharoplasty as compared to other patients not considering such procedures 2) patients before and after undergoing blepharoplasty. The results of these investigations can go towards establishing LLT as an important objective parameter to account for before and after blepharoplasty.
Conditions
- Lipid Thickness
Interventions
- DEVICE
-
Tear Science LipiView
The LipiView is a non-invasive instrument that captures live, special and digital images of your tear film and measures its lipid content and quality. This is a standardized test that quantifies your lipid to help your eye doctor determine if you should undergo the LipiFlow procedure or other tear therapies that would treat your condition. In effect, the LipiView allows your eye doctor to visualize your tear films.
Sponsors & Collaborators
-
Singapore National Eye Centre
lead OTHER_GOV
Principal Investigators
-
Louis Tong, Phd · Singapore National Eye Centre
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- Singapore
Study Locations
More Related Trials
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy
NCT07329712 ·Status: RECRUITING
-
Effect of Lipid Based Eye Drops on Tear Film Lipid Layer Thickness
NCT03399292 ·Status: COMPLETED
-
Treatment of Meibomian Gland Dysfunction
NCT01683318 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FID 114657 on Tear Film Lipid Layer Thickness
NCT00848068 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 ·Status: COMPLETED ·Phase: NA
-
Tear Film Thickness Measured Using a Novel Technique
NCT01014780 ·Status: COMPLETED
-
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
NCT02102464 ·Status: COMPLETED ·Phase: NA
-
Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye
NCT05923528 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Evaluation of the Tear Film
NCT00761917 ·Status: COMPLETED
-
Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
NCT05288582 ·Status: COMPLETED ·Phase: NA
-
Effect of Thermal Pulsation System (Lipiflow) Treatment for Ocular Surface Disease Due to Meibomian Gland Dysfunction
NCT03843983 ·Status: COMPLETED ·Phase: NA
-
Diurnal Variation of Tear Meniscus and Tear Osmolarity
NCT01206244 ·Status: COMPLETED
-
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
NCT01808560 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Light-based Therapies for Dry Eye Disease
NCT06004895 ·Status: COMPLETED ·Phase: NA
-
Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate
NCT01692652 ·Status: COMPLETED ·Phase: NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
NCT03658811 ·Status: COMPLETED ·Phase: NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT03055832 ·Status: COMPLETED ·Phase: NA
-
Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
NCT01552174 ·Status: COMPLETED
-
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT02992392 ·Status: UNKNOWN ·Phase: NA
-
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Diurnal Variation in Tear Osmolarity
NCT01321424 ·Status: COMPLETED
-
Effectiveness and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction
NCT03518398 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
NCT03956225 ·Status: COMPLETED ·Phase: NA